Home > Healthcare > Analytical Instruments > Lab Equipment and Supplies > Serum Separation Gel Market

Serum Separation Gel Market Share

Report ID: GMI8814
Published Date: Apr 2024
Report Format: PDF

Download Free Sample

Serum Separation Gel Market Share

The serum separation gel industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products based on different technologies is among a key market strategy. Some of the leading industry players have a notable presence in the market.

Serum Separation Gel Market Companies

Some of the eminent market participants operating in the serum separation gel industry include:

Becton, Dickinson and Company
BIOSIGMA S.p.A.
Bio-Rad Laboratories, Inc.
Cardinal Health, Inc.
Danaher Corporation
FL MEDICAL s.r.l.
Greiner AG
InterVacTechnology
Qiagen N.V.
Sekisui Chemical CO., LTD.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The serum separation gel industry crossed USD 7.7 billion in 2023 and is estimated to reach over USD 13 billion by 2032, driven by the increasing prevalence of chronic diseases, such as cardiovascular diseases, diabetes, and cancer.

The blood banks end-use segment in the serum separation gel industry accounted for USD 3.4 billion in 2023 and is set to gain traction by 2032, owing to the ability to improve the safety and efficacy of blood products collected and processed by blood banks.

North America serum separation gel market held a revenue share of 40.6% in 2023 and is predicted to witness substantial growth by 2032, driven by a well-developed healthcare infrastructure, including state-of-the-art clinical laboratories.

Becton, Dickinson and Company, BIOSIGMA S.p.A., Bio-Rad Laboratories, Inc, Cardinal Health, Inc, Danaher Corporation, FL MEDICAL s.r.l. and Greiner AG among others.